MetaADEDB 2.0 @ LMMD
Iron citrate
(HUTBITLDXCEAPZ-UHFFFAOYSA-N)
Structure
SMILES
OC(=O)C(CC(=O)O)(CC(=O)O)O.[Fe]
Molecular Formula:
C6H8FeO7
Molecular Weight:
247.969
Log P:
-1.2510
Hydrogen Bond Acceptor:
7
Hydrogen Bond Donor:
4
TPSA:
132.13
CAS Number(s):
2338-05-8
Synonym(s)
1.
Iron citrate
2.
Auryxia
External Link(s)
PubChem Compound9881379
4989393
ChEBI144421
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Transferrin saturation increasedFAERS: 68US FAERS
2ConstipationFAERS: 41US FAERS
3Prescribed overdoseFAERS: 40US FAERS
4Cardiac ArrestFAERS: 39US FAERS
5PruritusFAERS: 26US FAERS
6NauseaFAERS: 25US FAERS
7VomitingFAERS: 25US FAERS
8Myocardial InfarctionFAERS: 22US FAERS
9Drug ineffectiveFAERS: 20US FAERS
10Abdominal discomfortFAERS: 18US FAERS
11Abdominal PainFAERS: 17US FAERS
12PneumoniaFAERS: 10US FAERS
13Blood iron increasedFAERS: 9US FAERS
14Intentional product misuseFAERS: 9US FAERS
15AlopeciaFAERS: 8US FAERS
16Chest PainFAERS: 7US FAERS
17SepsisFAERS: 7US FAERS
18Abdominal symptomFAERS: 6US FAERS
19HypersensitivityFAERS: 6US FAERS
20InfectionFAERS: 6US FAERS
21OverdoseFAERS: 6US FAERS
22UrticariaFAERS: 6US FAERS
23DizzinessFAERS: 5US FAERS
24MalaiseFAERS: 5US FAERS
25CalciphylaxisFAERS: 4US FAERS
26Cerebrovascular accidentFAERS: 4US FAERS
27Clostridium difficile infectionFAERS: 4US FAERS
28DyspepsiaFAERS: 4US FAERS
29FlatulenceFAERS: 4US FAERS
30Intentional product use issueFAERS: 4US FAERS
31Limb injuryFAERS: 4US FAERS
32Procedural complicationFAERS: 4US FAERS
33ThrombosisFAERS: 4US FAERS
34Wrong technique in product usage processFAERS: 4US FAERS
35Blood glucose increasedFAERS: 3US FAERS
36Blood phosphorus increasedFAERS: 3US FAERS
37Blood potassium increasedFAERS: 3US FAERS
38Central Nervous System InfectionFAERS: 3US FAERS
39ChromaturiaFAERS: 3US FAERS
40Drug dispensing errorFAERS: 3US FAERS
41Drug prescribing errorFAERS: 3US FAERS
42GangreneFAERS: 3US FAERS
43Mental impairmentFAERS: 3US FAERS
44Pulmonary EmbolismFAERS: 3US FAERS
45Therapy cessationFAERS: 3US FAERS
46ArteriosclerosisFAERS: 2US FAERS
47Blood albumin decreasedFAERS: 2US FAERS
48Blood glucose abnormalFAERS: 2US FAERS
49Blood phosphorus decreasedFAERS: 2US FAERS
50Brain HypoxiaFAERS: 2US FAERS
51Cardiac DeathFAERS: 2US FAERS
52Cardiac pacemaker adjustmentFAERS: 2US FAERS
53CellulitisFAERS: 2US FAERS
54Chest discomfortFAERS: 2US FAERS
55Complication associated with deviceFAERS: 2US FAERS
56Deep Vein ThrombosisFAERS: 2US FAERS
57DysgeusiaFAERS: 2US FAERS
58Fluid overloadFAERS: 2US FAERS
59Gastrointestinal PainFAERS: 2US FAERS
60HeadacheFAERS: 2US FAERS
61Mental status changesFAERS: 2US FAERS
62MyalgiaFAERS: 2US FAERS
63No adverse eventFAERS: 2US FAERS
64OsteomyelitisFAERS: 2US FAERS
65PainFAERS: 2US FAERS
66PalpitationsFAERS: 2US FAERS
67PeritonitisFAERS: 2US FAERS
68Post procedural complicationFAERS: 2US FAERS
69PregnancyFAERS: 2US FAERS
70Product use issueFAERS: 2US FAERS
71Respiratory FailureFAERS: 2US FAERS
72Respiratory arrestFAERS: 2US FAERS
73Respiratory distressFAERS: 2US FAERS
74Septic ShockFAERS: 2US FAERS
75Skin irritationFAERS: 2US FAERS
76ThrombocytopeniaFAERS: 2US FAERS
77Urine output increasedFAERS: 2US FAERS
78Wound InfectionFAERS: 2US FAERS
79Abdominal massFAERS: 1US FAERS
80Adverse eventFAERS: 1US FAERS
81Alanine Aminotransferase IncreasedFAERS: 1US FAERS
82Anal FissureFAERS: 1US FAERS
83AstheniaFAERS: 1US FAERS
84Blood alkaline phosphatase increasedFAERS: 1US FAERS
85Blood iron decreasedFAERS: 1US FAERS
86Blood phosphorus abnormalFAERS: 1US FAERS
87Blood urine presentFAERS: 1US FAERS
88CalcinosisFAERS: 1US FAERS
89Cardio-respiratory distressFAERS: 1US FAERS
90ChokingFAERS: 1US FAERS
91DehydrationFAERS: 1US FAERS
92Drug administered to patient of inappropriate ageFAERS: 1US FAERS
93Drug-disease interactionFAERS: 1US FAERS
94Erectile dysfunctionFAERS: 1US FAERS
95FatigueFAERS: 1US FAERS
96FlushingFAERS: 1US FAERS
97Gastric ulcerFAERS: 1US FAERS
98Hepatic siderosisFAERS: 1US FAERS
99HypercapniaFAERS: 1US FAERS
100HypotensionFAERS: 1US FAERS
101Implant site infectionFAERS: 1US FAERS
102Intentional dose omissionFAERS: 1US FAERS
103Intestinal ObstructionFAERS: 1US FAERS
104Intracranial AneurysmFAERS: 1US FAERS
105Iron OverloadFAERS: 1US FAERS
106Lip swellingFAERS: 1US FAERS
107Medication ErrorFAERS: 1US FAERS
108Muscle tightnessFAERS: 1US FAERS
109NervousnessFAERS: 1US FAERS
110Occult blood positiveFAERS: 1US FAERS
111Oral mucosal eruptionFAERS: 1US FAERS
112ParathyroidectomyFAERS: 1US FAERS
113Peptic ulcer helicobacterFAERS: 1US FAERS
114Procedural hypotensionFAERS: 1US FAERS
115Product label confusionFAERS: 1US FAERS
116Product prescribing errorFAERS: 1US FAERS
117Product quality issueFAERS: 1US FAERS
118Product use complaintFAERS: 1US FAERS
119PsoriasisFAERS: 1US FAERS
120Rectal abscessFAERS: 1US FAERS
121ScabFAERS: 1US FAERS
122Tongue exfoliationFAERS: 1US FAERS
123Transcription medication errorFAERS: 1US FAERS
124TremorFAERS: 1US FAERS
125Urinary tract infectionFAERS: 1US FAERS
126jaundiceFAERS: 1US FAERS
127treatment failureFAERS: 1US FAERS
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120237

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.